Terms: = Pancreatic cancer AND MUC16, CA125, CA-125 AND Staging
11 results:
1. The role of staging laparoscopy in pancreatic adenocarcinoma and its effect on patients' survival.
Jambor MA; Ashrafizadeh A; Nahm CB; Clarke SJ; Pavlakis N; Kneebone A; Hruby G; Gill AJ; Mittal A; Samra JS
World J Surg Oncol; 2022 Oct; 20(1):337. PubMed ID: 36217193
[TBL] [Abstract] [Full Text] [Related]
2. Long-term outcomes of standard versus extended lymphadenectomy in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: A Chinese multi-center prospective randomized controlled trial.
Wang W; Lou W; Xu Z; Chen H; Shen Z; Deng X; Peng C; Liu Y; Shen B
J Adv Res; 2023 Jul; 49():151-157. PubMed ID: 36198383
[TBL] [Abstract] [Full Text] [Related]
3. Laparoscopic biopsy and staging for locally advanced pancreatic cancer: experiences of 76 consecutive patients in a single institution.
Lin X; Lin R; Lu F; Yang Y; Wang C; Fang H; Chen Y; Huang H
Langenbecks Arch Surg; 2021 Nov; 406(7):2315-2323. PubMed ID: 34021414
[TBL] [Abstract] [Full Text] [Related]
4. A Nomogram for Individual Prediction of Poor Prognosis After Radical Surgery in Patients with Primary pancreatic Duct Adenocarcinoma.
Zhai S; Huo Z; Ying X; Jin J; Wang Y; Lu X; Deng X
Med Sci Monit; 2020 Feb; 26():e918882. PubMed ID: 32088726
[TBL] [Abstract] [Full Text] [Related]
5. Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced pancreatic Adenocarcinoma.
Lin C; Verma V; Lazenby A; Ly QP; Berim LD; Schwarz JK; Madiyalakan M; Nicodemus CF; Hollingsworth MA; Meza JL; Are C; Padussis J; Grem JL
Am J Clin Oncol; 2019 Oct; 42(10):755-760. PubMed ID: 31513018
[TBL] [Abstract] [Full Text] [Related]
6. cancer Antigen 125 (ca125, muc16) Protein Expression in the Diagnosis and Progression of pancreatic Ductal Adenocarcinoma.
Jiang K; Tan E; Sayegh Z; Centeno B; Malafa M; Coppola D
Appl Immunohistochem Mol Morphol; 2017 Oct; 25(9):620-623. PubMed ID: 27093451
[TBL] [Abstract] [Full Text] [Related]
7. Serum CA242, CA199, ca125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in pancreatic cancer Patients.
Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
[TBL] [Abstract] [Full Text] [Related]
8. Surgical treatment of periampullary cancer--review of 766 surgical experiences of 8 hospitals.
Kim SM; Kim SH; Choi SY; Kim YC
J Korean Med Sci; 1992 Dec; 7(4):297-303. PubMed ID: 1299231
[TBL] [Abstract] [Full Text] [Related]
9. Present status of periampullary cancer treatment in Korea.
Kim SM
Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1164-76. PubMed ID: 1514830
[TBL] [Abstract] [Full Text] [Related]
10. Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.
Sakamoto K; Haga Y; Yoshimura R; Egami H; Yokoyama Y; Akagi M
Gut; 1987 Mar; 28(3):323-9. PubMed ID: 3471687
[TBL] [Abstract] [Full Text] [Related]
11. Clinical usefulness of three monoclonal antibody-defined tumor markers: CA 19-9, CA 50, and CA 125.
Szymendera JJ
Tumour Biol; 1986; 7(5-6):333-42. PubMed ID: 2437641
[TBL] [Abstract] [Full Text] [Related]
